Skip to main content
. 2020 May 11;75:e1619. doi: 10.6061/clinics/2020/e1619

Table 4.

Relationship between PLT and HFMD risk and progression in the different models.

Index Crude model Minimally adjusted model Fully adjusted model
PLT count #0.996 (0.990-1.001), 0.097 #0.993 (0.984-1.003), 0.172 #0.999 (0.998-1.0003), 0.999
*1.008 (1.001-1.015), 0.02 *1.008 (1.002-1.015), 0.016 *1.009 (1.001-1.018), 0.036
PLT quartile
    Q1 #Reference #Reference #Reference
*Reference *Reference *Reference
    Q2 #0.345 (0.112-1.054), 0.062 #0.672 (0.071-6.347), 0.729 #0.999 (0.00001-1.0004), 0.999
*2.909 (0.489-17.287), 0.240 *2.585 (0.429-15.590), 0.300 *3.021 (0.393-23.213), 0.288
    Q3 #0.409 (0.133-1.262), 0.119 #0.247 (0.029-2.094), 0.199 #0.999 (0.00001-1.0003), 0.999
*3.333 (0.595-18.674), 0.171 *4.019 (0.691-23.391), 0.122 *2.728 (0.317-23.456), 0.361
    Q4 #0.375 (0.121-1.165), 0.105 #0.237 (0.029-1.956), 0.181 #0.999 (0.00001-1.0005), 0.999
*5.091(0.966-26.844), 0.055 *5.337 (1.002-28.419), 0.049 *6.585 (0.822-52.724), 0.076
P for trend #0.136 #0.122 #0.999
*0.054 *0.037 *0.090

HFMD: hand, foot, and mouth disease, PLT: platelet, crude model: adjusted for none, minimally adjusted model: adjusted for age and gender, fully adjusted model: adjusted for age, gender, WBC count and HB, ALB, ALT, AST, Scr, Ca, P, and Mg levels;

#

relationship between PLT count and HFMD risk

*

relationship between PLT count and HFMD progression.